Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00221871
Status:
UNKNOWN
Last Update Posted:
2006-10-11
First Post:
2005-09-20
Brief Title:
Proper Dosage of Ketamine in Intravenous Regional Anesthesia
Sponsor:
University Health Network Toronto
Organization:
University Health Network Toronto
Study Overview
Official Title:
Proper Dosage of Intravenous Ketamine When Used as an Adjuvant to Lidocaine in Intravenous Regional Anesthesia IVRA
Status:
UNKNOWN
Status Verified Date:
2005-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Ketamine added to Lidocaine can increase duration of pain relief following intraveonous regional anesthesia IVRA The purpose of this dose response study is to determine the minimum effective dosage of intravenous Ketamine added to 3 mgkg of Lidocaine We anticipate that one dosage will provide us with the proper balance between sufficient anesthesia and minimal side effects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None